We are live on ! Find out more
DRIO icon

DarioHealth
DRIO

Fund managers haven’t disclosed any holdings of DRIO yet.

DRIO Hedge Fund Activity: Q1 2026 in Review

21 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q1 2026, worth a combined $6.76M — down 19% from $8.37M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new DRIO positions and 3 closed out — a net gain of 5 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $495K. The largest seller was Kestra Advisory Services, exiting entirely with an estimated $35.3K sold.

  • 21 institutional investors held DarioHealth (DRIO) as of Q1 2026, up from 17 in Q4 2025.
  • Funds reported $6.76M of DarioHealth stock for Q1 2026, down 19% quarter-over-quarter.
  • 8 funds opened new DarioHealth positions in Q1 2026 and 3 closed out, a net change of +5 holders.
  • The largest DarioHealth buyer in Q1 2026 was Nantahala Capital Management, an estimated $495K added.
  • The largest DarioHealth seller in Q1 2026 was Kestra Advisory Services, an estimated $35.3K sold.

Based on aggregated 13F filings for Q1 2026.